(206 days)
Not Found
No
The summary describes sensors for acquiring ECG and heart sound signals and transmitting them to a system for evaluation. There is no mention of AI, ML, or any algorithms that would process the data using these technologies. The performance studies focus on compliance with standards for electrodes and biological evaluation, not algorithmic performance.
No
The device is described as a sensor for acquiring heart sounds and ECG signals to aid in diagnosis and evaluation of patient status, not to provide treatment.
Yes
The "Intended Use / Indications for Use" section states that the device is used "to aid in diagnosis," which directly indicates a diagnostic purpose.
No
The device description explicitly states the Audicor Sensors are physical devices with conductive patient-contact surfaces and a microphone, indicating they are hardware components.
Based on the provided information, the Audicor® Sensors are not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to provide information about a person's health. These tests are performed outside of the body (in vitro).
- Audicor Sensor Function: The Audicor Sensors are described as devices that acquire heart sounds and ECG electrical signals directly from the patient's body by being placed on the chest wall. They transmit these signals to a system for evaluation.
- Lack of Sample Analysis: There is no mention of the Audicor Sensors collecting or analyzing any biological samples from the patient. Their function is to capture physiological signals from the body itself.
Therefore, the Audicor Sensors fall under the category of devices that acquire physiological data directly from the patient, rather than performing tests on samples taken from the patient.
N/A
Intended Use / Indications for Use
The Audicor® Sensors are a family of dual-function sensors for use on adult patients (≥ 18 years) for acquisition of both heart sounds and ECG electrical signals and to transmit these signals to a compatible Audicor system to allow for the evaluation of patient status, to aid in diagnosis, and to determine effects of treatment on ECG and hemodynamics.
There are disposable and reusable versions of the Audicor Sensor. Both can be used in the collection of resting ECG reports. The disposable Audicor Sensor is also intended for longer term monitoring applications of up to 48 hours.
Product codes
DRX, DQD
Device Description
The Audicor Sensors are a group of devices that are intended for use with Audicor-enabled ECG/heart sounds detections systems. Sensors are designed with conductive patient-contact surfaces to enable capture of ECG data, and include a microphone for detection of heart sounds. The devices are intended for use on the chest wall in the V3 and/or V4 positions.
Audicor sensors are available in two versions:
- Single-use disposable sensors, for use up to 48 hours
- Durable reusable sensors
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
chest wall in the V3 and/or V4 positions
Indicated Patient Age Range
adult patients (≥ 18 years)
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Audicor sensors have been tested to the applicable requirements of the following standards, and shown to comply.
• ANSI/AAMI EC12:2000 - Disposable ECG Electrodes
• ISO 10993-1:2003, Biological Evaluation of Medical Devices - Evaluation and testing.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2360 Electrocardiograph electrode.
(a)
Identification. An electrocardiograph electrode is the electrical conductor which is applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9. The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Electrocardiograph Electrodes.” See § 870.1(e) for availability information of guidance documents.
0
SEP 2 5 2008
:
Summary of Safety and Effectiveness
As required by 21 CFR, part 807.92
As required by 21 CFR, part 807.92
| Submitted By: | Inovise Medical, Inc.
10565 SW Nimbus Ave, Suite 100
Portland, OR 97233-4311
Phone 503-431-3849
Fax 503-431-3801 |
|-----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | Kendra Rathkey
Manager, Quality and Regulatory |
| Date Prepared: | August 26, 2008 |
| Proprietary
Name: | AUDICOR Sensor 2.0 and 3.0 |
| Common/ Usual
Name: | ECG/ Heart Sound Sensor |
| Classification: | 870.2360, DRX, class II, Electrocardiograph electrode
870.1875, DQD, class II, Stethoscope, electronic |
| Performance
Standards: | ANSI/AAMI EC12:2000 |
| Intended Use: | The Audicor® Sensors are a family of dual-function sensors for use on adult
patients (≥ 18 years) for acquisition of both heart sounds and ECG electrical
signals and to transmit these signals to a compatible Audicor system to allow for
the evaluation of patient status, to aid in diagnosis, and to determine effects of
treatment on ECG and hemodynamics.
There are disposable and reusable versions of the Audicor Sensor. Both can be
used in the collection of resting ECG reports. The disposable Audicor Sensor is
also intended for longer term monitoring applications of up to 48 hours. |
| Device
Description: | The Audicor Sensors are a group of devices that are intended for use with Audicor-
enabled ECG/heart sounds detections systems. Sensors are designed with
conductive patient-contact surfaces to enable capture of ECG data, and include a
microphone for detection of heart sounds. The devices are intended for use on the
chest wall in the V3 and/or V4 positions.
Audicor sensors are available in two versions:
- Single-use disposable sensors, for use up to 48 hours
- Durable reusable sensors |
| Test Summary
& Conclusion: | The Audicor sensors have been tested to the applicable requirements of the
following standards, and shown to comply.
• ANSI/AAMI EC12:2000 - Disposable ECG Electrodes
• ISO 10993-1:2003, Biological Evaluation of Medical Devices - Evaluation and
testing. |
| Substantial
Equivalence: | The Audicor Sensors are substantially equivalent to the Audicor™ COR Sensor
(K030316). Modifications include:
• Extended contact duration up to 48 hours for single-use sensor
• Added reusable sensor to the product line |
| Technological
Characteristics: | The Audicor sensors included in this submission are technologically equivalent to
the predicate in that all are dual function sensors (ECG/heart sounds detection)
and all are designed for use with Audicor-enabled ECG/heart sounds systems. |
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES. USA" arranged around the perimeter. Inside the circle is a stylized emblem featuring a symbol that resembles an abstract caduceus or a stylized representation of human services.
Public Health Service
SEP 2 5 2008
ood and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Inovise Medical Inc. c/o Ms. Kendra Rathkey Manager, Quality and Regulatory 10565 SW Nimbus Avenue, Suite 100 Portland, OR 97223-4311
Re: K080602
Trade/Device Name: Audicor Sensors 2,0 and 3,0 Regulation Number: 21 CFR 870.2360 Regulation Name: Electrocardiograph electrode Regulatory Class: Class II Product Code: DRX, DQD Dated: September 19, 2008 Received: September 22, 2008
Dear Ms. Rathkey:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
2
Page 2 - Ms. Kendra Rathkey
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) rmoreteet notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Dma R. Lachner
1 Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known): K080602
Device Name: Audicor Sensor 2.0 and 3.0
Indications For Use:
The Audicor® Sensors are a family of dual-function sensors for use on adult patients (≥ 18 years) for acquisition of both heart sounds and ECG electrical signals and to transmit these signals to a compatible Audicor system to allow for the evaluation of patient status, to aid in diagnosis, and to determine effects of treatment on ECG and hemodynamics.
There are disposable and reusable versions of the Audicor Sensor. Both can be used in the collection of resting ECG reports. The disposable Audicor Sensor is also intended for longer term monitoring applications of up to 48 hours.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR ' Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
R. vchmer
(Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number_Ku8062